Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report)’s stock price shot up 0.7% during mid-day trading on Monday . The stock traded as high as $1.4272 and last traded at $1.38. Approximately 73,869 shares traded hands during trading, a decline of 93% from the average session volume of 1,049,645 shares. The stock had previously closed at $1.37.
Virios Therapeutics Trading Up 1.4%
The firm has a 50 day moving average of $1.59 and a 200-day moving average of $2.26. The company has a market cap of $26.96 million, a P/E ratio of -5.19 and a beta of 1.58.
Virios Therapeutics Company Profile
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
Further Reading
- Five stocks we like better than Virios Therapeutics
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
